Eyenovia MiDD Usability Study

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

March 17, 2018

Study Completion Date

March 17, 2018

Conditions

Intraocular Pressure

Interventions

DRUG

Latanoprost

Latanoprost ophthalmic solution administered as a microdose spray

DRUG

Latanoprost

Latanoprost ophthalmic solution administered as an eyedrop

Trial Locations (1)

Clinica de Ojos Orillac-Calvo, Panama City